California Public Employees Retirement System’s Zentalis Pharmaceuticals ZNTL Stock Holding History

California Public Employees Retirement System’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,256	Closed	-$2.53M	–	2954
2021 Q1	$2.53M	Sell	58,256 -5,396	-8%	-$232K	﹤0.01%	1870
2020 Q4	$3.31M	Buy	63,652 +37,449	+143%	+$1.69M	﹤0.01%	1680
2020 Q3	$857K	Buy	26,203 +3,344	+15%	+$117K	﹤0.01%	2386
2020 Q2	$1.1M	Buy	+22,859	New	+$877K	﹤0.01%	2167

Other funds holding ZNTL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

California Public Employees Retirement System's ZNTL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2021, closing a stake of 58,256 shares — an estimated $2.53M sold.

California Public Employees Retirement System first reported a position in ZNTL in Q2 2020 and held it in 4 quarters. The position peaked at $3.31M in Q4 2020. 120 funds tracked by Wall St. Rank hold ZNTL as of Q2 2021.

California Public Employees Retirement System reported no remaining Zentalis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 58,256 Zentalis Pharmaceuticals shares in Q2 2021, an estimated $2.53M.
California Public Employees Retirement System first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 4 quarters.
California Public Employees Retirement System's Zentalis Pharmaceuticals position peaked at $3.31M in Q4 2020.
120 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.